X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (53) 53
humans (47) 47
hematology (42) 42
child (37) 37
male (35) 35
adolescent (33) 33
female (33) 33
child, preschool (29) 29
transplantation (27) 27
infant (23) 23
children (18) 18
treatment outcome (18) 18
transplantation, homologous (15) 15
disease-free survival (14) 14
immunology (14) 14
remission induction (13) 13
hematopoietic stem cell transplantation (12) 12
bone-marrow-transplantation (11) 11
precursor cell lymphoblastic leukemia-lymphoma - therapy (11) 11
risk factors (11) 11
abridged index medicus (10) 10
adult (10) 10
chemotherapy (10) 10
leukemia (10) 10
pediatrics (10) 10
stem cells (10) 10
stem-cell transplantation (10) 10
hematology, oncology and palliative medicine (9) 9
hematopoietic stem cell transplantation - adverse effects (9) 9
recurrence (9) 9
retrospective studies (9) 9
versus-host-disease (9) 9
2nd remission (8) 8
middle aged (8) 8
oncology (8) 8
precursor cell lymphoblastic leukemia-lymphoma - mortality (8) 8
allogeneic transplantation (7) 7
bone marrow transplantation (7) 7
cancer (7) 7
graft vs host disease - drug therapy (7) 7
hematopoietic stem cell transplantation - methods (7) 7
hematopoietic stem cells (7) 7
prospective studies (7) 7
relapse (7) 7
survival analysis (7) 7
survival rate (7) 7
unrelated donors (7) 7
young adult (7) 7
childhood (6) 6
extracorporeal photochemotherapy (6) 6
graft vs host disease - etiology (6) 6
graft vs host disease - immunology (6) 6
gvhd (6) 6
immunotherapy (6) 6
minimal residual disease (6) 6
therapy (6) 6
time factors (6) 6
acute lymphoblastic leukemia (5) 5
analysis (5) 5
antineoplastic agents - therapeutic use (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
blood (5) 5
bone-marrow (5) 5
chronic disease (5) 5
graft (5) 5
graft vs host disease - mortality (5) 5
leukemia - therapy (5) 5
photopheresis (5) 5
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (5) 5
prognosis (5) 5
stem cell transplantation (5) 5
tissue donors (5) 5
acute disease (4) 4
acute myeloid-leukemia (4) 4
aged (4) 4
care and treatment (4) 4
flow cytometry (4) 4
graft vs host disease - epidemiology (4) 4
graft vs host disease - therapy (4) 4
health aspects (4) 4
histocompatibility testing (4) 4
survival (4) 4
1st remission (3) 3
acute lymphatic leukemia (3) 3
acute lymphoblastic-leukemia (3) 3
acute lymphocytic leukemia (3) 3
article (3) 3
biomarkers - blood (3) 3
bmt (3) 3
bone marrow (3) 3
bone marrow transplantation - adverse effects (3) 3
cell biology (3) 3
chronic graft (3) 3
chronic myelogenous leukemia (3) 3
clinical-trials (3) 3
cohort studies (3) 3
combined modality therapy (3) 3
drug administration schedule (3) 3
education (3) 3
experience (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 02/2018, Volume 378, Issue 5, pp. 439 - 448
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 9/2013, Volume 57, Issue 6, pp. 794 - 802
Background. The objective of this analysis was to investigate prognostic factors that influence the outcome of Epstein-Barr virus (EBV)—related posttransplant... 
Health outcomes | Immunosuppression | Lymphoproliferative disorders | Mortality | Predisposing factors | Viral diseases | Transplantation | Graft vs host disease | Epstein Barr virus infections | ARTICLES AND COMMENTARIES | Blood | hematopoietic stem cell transplantation | risk factors | Epstein-Barr virus | post-transplant lymphoproliferative disorder | prognostic model | INFECTIOUS DISEASES | MANAGEMENT | PROGNOSTIC-FACTORS | LOAD | SCT | MICROBIOLOGY | IMMUNOLOGY | RECIPIENTS | VERSUS-HOST-DISEASE | REACTIVATION | LYMPHOMA | PTLD | LYMPHOCYTES | Prognosis | Humans | Middle Aged | Child, Preschool | Infant | Epstein-Barr Virus Infections - surgery | Viral Load | Herpesvirus 4, Human - isolation & purification | Adult | Retrospective Studies | Child | Epstein-Barr Virus Infections - epidemiology | Lymphoproliferative Disorders - surgery | Epstein-Barr Virus Infections - virology | Lymphoproliferative Disorders - virology | Risk Factors | Kaplan-Meier Estimate | Europe - epidemiology | Hematopoietic Stem Cell Transplantation | Rituximab | Epstein-Barr Virus Infections - drug therapy | Lymphoproliferative Disorders - epidemiology | DNA, Viral - blood | Adolescent | Lymphoproliferative Disorders - drug therapy | Aged | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Immunologic Factors - therapeutic use | Prescription drugs | Hematology | Stem cells | Drug therapy | Multivariate analysis | Blood diseases | Risk factors | Clinical outcomes | Index Medicus
Journal Article
1988, Colección Las Alternativas pedagógicas., 371 p. --
Book
Journal Article
Journal Article
Leukemia, ISSN 0887-6924, 07/2018, Volume 32, Issue 7, pp. 1657 - 1669
A total of 156 patients (age range 1.3-18.0 years, median 13.2 years; 91 (58.3%) male) with newly diagnosed CML (N = 146 chronic phase (CML-CP), N = 3... 
CHRONIC MYELOGENOUS LEUKEMIA | TYROSINE KINASE INHIBITORS | RANDOMIZED CML | ONCOLOGY | COMPLETE MOLECULAR REMISSION | LONG-TERM SURVIVAL | MANAGING CHILDREN | RECEIVING IMATINIB | DOSE IMATINIB | STEM-CELL TRANSPLANTATION | HEMATOLOGY | EUROPEAN-LEUKEMIANET | Prognosis | Humans | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Child, Preschool | Infant | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Imatinib Mesylate - therapeutic use | Neoplasm Grading | Antineoplastic Agents - adverse effects | Imatinib Mesylate - adverse effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Treatment Failure | Imatinib Mesylate - administration & dosage | Female | Child | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - mortality | Treatment Outcome | Combined Modality Therapy | Disease Progression | Protein Kinase Inhibitors - administration & dosage | Protein Kinase Inhibitors - therapeutic use | Bone Marrow - pathology | Adolescent | Biomarkers | Neoplasm Staging | Adolescence | Imatinib | Myeloid leukemia | Complications | Leukemia | Stem cell transplantation | Transplantation | Chronic myeloid leukemia | Survival | Patients | Molecular chains | Intolerance | Side effects | Failure analysis | Stem cells | Children | Adolescents | Index Medicus
Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2014, Volume 20, Issue 3, pp. 375 - 381
Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2010, Volume 16, Issue 9, pp. 1293 - 1301
Journal Article
BLOOD, ISSN 0006-4971, 12/2018, Volume 132, Issue 24, pp. 2594 - 2607
Traditionally, hematopoietic stem cell transplantation (HSCT) from both HLA-matched related and unrelated donors (UD) has been used for treating children with... 
STATISTICAL-METHODS | HIGH-DOSE CYCLOPHOSPHAMIDE | FREE SURVIVAL | ACUTE MYELOID-LEUKEMIA | BONE-MARROW TRANSPLANTS | SELECTIVE DEPLETION | HEMATOLOGY | MINIMAL RESIDUAL DISEASE | VERSUS-HOST-DISEASE | HEMATOPOIETIC TRANSPLANTATION | CD3/CD19 DEPLETION | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article